The Sarsia Seed Management team comes from a wide variety of backgrounds with a collective expertise which is extensive not only with respect to the various investment areas on which the fund focuses, but also with respect to best practice/effective fund administration. The team, through its association with the Fund board and the commercialization/investment cluster, has access to an extensive network of contacts including technical, industrial, academic and financial associates both nationally and internationally.
+47 90 93 28 72
Erlend brings 20 years of experience from R&D based IPR, project- and business development from Christian Michelsen Research, Forinnova and Sarsia Innovation. Has managed several turnaround processes and negotiated a large number of international contracts, licenses and trade exits. Broad board experience.
Ph.D in microbiology
+47 90 06 23 03
Øivind has over 13 years of research experience in molecular biology and fish disease, and 5 years in commercialising research based projects in biology, aqua culture, medicine and biotechnology. He has several years of managerial and board experience from position with Sarsia Innovation AS.
+47 95 27 28 39
Marit Wick has 20 years experience from financial and administrative management, as well as strategic-, organizational- and M&A management experience from private and publicly traded industrial companies within the off-shore industry, food industry, real estate and life science sector
Jon Trygve Berg
Partner, Energy and Technology
Siv. Ing., MBA, CEFA
+47 95 23 76 49
Jon brings 15 years of oil/gas technology experience. Jon sits on the board of Weyland, WindSim, Sorbwater and EnSo. He has experience from Det norske Veritas and has been the manager of the early start ups GexCon AS (Christian Michelsen Research) and Petroleum Engineering & Consulting AS. He has been the CTO of IT/speech technology start-up NST.
Partner, Life Science Investments
+47 90 59 72 90
Farzad’s background is in preclinical and clinical research with drug development experience from US based global pharma in the US and Norway. He has 17 years of experience in commercializing medical/biotech projects from the Sarsia investment system. Farzad received his doctorate in pharmacology from the University of Edinburgh Medical School, UK and postdoctoral training from Haukeland University Hospital Bergen, Norway.